Publication | Open Access
Results of a 2‐arm Phase II study of 9‐nitrocamptothecin in patients with advanced soft‐tissue sarcomas
32
Citations
7
References
2003
Year
9-NC is well tolerated but inactive in GI leiomyosarcomas and has minimal activity in previously treated patients with STS.
| Year | Citations | |
|---|---|---|
Page 1
Page 1